Full Press Release Details
Guidance Including the Impact of Acquired IPR D and Milestones Expense
| (in millions, except per share data) | Quarter Ended September 30, 2022 | Full-Year Ended December 31, 2022 | |||||||||||||||||||||
| Acquired IPR D and Milestones Expense | Adjusted Diluted EPS Range | Acquired IPR D and Milestones Expense | Adjusted Diluted EPS Range | ||||||||||||||||||||
| Low | High | Low | High | ||||||||||||||||||||
| Previously announced guidance excluding Q3 2022 acquired IPR D and milestones expense | $ | - | $ | 3.55 | $ | 3.59 | $ | 414 | $ | 13.78 | $ | 13.98 | |||||||||||
| Q3 2022 acquired IPR D and milestones expense | 40 | (0.02) | (0.02) | 40 | (0.02) | (0.02) | |||||||||||||||||
| Guidance including Q3 2022 acquired IPR D and milestones expense a | $ | 40 | $ | 3.53 | $ | 3.57 | $ | 454 | $ | 13.76 | $ | 13.96 |
a The Company's 2022 adjusted diluted EPS guidance excludes any impact from acquired IPR D and milestones expense that may be incurred beyond the third quarter of 2022, as both cannot be reliably forecasted.